JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 26, 2006; DOI: 10.1124/jpet.106.107367


0022-3565/06/3193-991-997$20.00
JPET 319:991-997, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.107367v1
319/3/991    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhuang, S.
Right arrow Articles by Schnellmann, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhuang, S.
Right arrow Articles by Schnellmann, R. G.

PERSPECTIVES IN PHARMACOLOGY

A Death-Promoting Role for Extracellular Signal-Regulated Kinase

Shougang Zhuang, and Rick G. Schnellmann

Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina

Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2), which are members of the mitogen-activated protein kinase superfamily, have been well characterized and are known to be involved in cell survival; however, recent evidence suggests that the activation of ERK1/2 also contributes to cell death in some cell types and organs under certain conditions. For example, ERK1/2 is activated in neuronal and renal epithelial cells upon exposure to oxidative stress and toxicants and deprivation of growth factors, and inhibition of the ERK pathway blocks apoptosis. ERK activation also occurs in animal models of ischemia- and trauma-induced brain injury and cisplatin-induced renal injury, and inactivation of ERK reduces the extent of tissue damage. In some studies, ERK has been implicated in apoptotic events upstream of mitochondrial cytochrome c release, whereas other studies have suggested the converse that ERK acts downstream of mitochondrial events and upstream of caspase-3 activation. ERK also can contribute to cell death through the suppression of the antiapoptotic signaling molecule Akt. Here we summarize the evidence and mechanism of ERK-induced apoptosis in both cell culture and in animal models.


Received May 6, 2006; accepted June 23, 2006.

Address correspondence to: Dr. Rick G. Schnellmann, Department of Pharmaceutical Sciences, Medical University of South Carolina, 280 Calhoun St., P. O. Box 250140, Charleston, SC 29425. E-mail: schnell{at}musc.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. Haimerl, A. Erhardt, G. Sass, and G. Tiegs
Down-regulation of the De-ubiquitinating Enzyme Ubiquitin-specific Protease 2 Contributes to Tumor Necrosis Factor-{alpha}-induced Hepatocyte Survival
J. Biol. Chem., January 2, 2009; 284(1): 495 - 504.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. S. Kim, G. B. Park, H.-K. Lee, H. Song, I.-H. Choi, W. J. Lee, and D. Y. Hur
Cross-Linking of B7-H1 on EBV-Transformed B Cells Induces Apoptosis through Reactive Oxygen Species Production, JNK Signaling Activation, and fasL Expression
J. Immunol., November 1, 2008; 181(9): 6158 - 6169.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Caretti, P. Bianciardi, R. Ronchi, M. Fantacci, M. Guazzi, and M. Samaja
Phosphodiesterase-5 Inhibition Abolishes Neuron Apoptosis Induced by Chronic Hypoxia Independently of Hypoxia-Inducible Factor-1{alpha} Signaling
Experimental Biology and Medicine, October 1, 2008; 233(10): 1222 - 1230.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Onozuka, A. Nakajima, K. Matsuzaki, R.-W. Shin, K. Ogino, D. Saigusa, N. Tetsu, A. Yokosuka, Y. Sashida, Y. Mimaki, et al.
Nobiletin, a Citrus Flavonoid, Improves Memory Impairment and A{beta} Pathology in a Transgenic Mouse Model of Alzheimer's Disease
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 739 - 744.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Ivanov, S. Krysov, M. S. Cragg, and T. Illidge
Radiation Therapy with Tositumomab (B1) Anti-CD20 Monoclonal Antibody Initiates Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase-Dependent Cell Death that Overcomes Resistance to Apoptosis
Clin. Cancer Res., August 1, 2008; 14(15): 4925 - 4934.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. L. Lomonaco, S. Kahana, M. Blass, Y. Brody, H. Okhrimenko, C. Xiang, S. Finniss, P. M. Blumberg, H.-K. Lee, and C. Brodie
Phosphorylation of Protein Kinase C{delta} on Distinct Tyrosine Residues Induces Sustained Activation of Erk1/2 via Down-regulation of MKP-1: ROLE IN THE APOPTOTIC EFFECT OF ETOPOSIDE
J. Biol. Chem., June 20, 2008; 283(25): 17731 - 17739.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Joo and A. M. Jetten
NF-{kappa}B-dependent Transcriptional Activation in Lung Carcinoma Cells by Farnesol Involves p65/RelA(Ser276) Phosphorylation via the MEK-MSK1 Signaling Pathway
J. Biol. Chem., June 13, 2008; 283(24): 16391 - 16399.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Zhuang, G. R. Kinsey, Y. Yan, J. Han, and R. G. Schnellmann
Extracellular Signal-Regulated Kinase Activation Mediates Mitochondrial Dysfunction and Necrosis Induced by Hydrogen Peroxide in Renal Proximal Tubular Cells
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 732 - 740.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. P. Rygiel, A. E. Mertens, K. Strumane, R. van der Kammen, and J. G. Collard
The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation
J. Cell Sci., April 15, 2008; 121(8): 1183 - 1192.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Ma, K. A. Bower, G. Chen, X. Shi, Z.-J. Ke, and J. Luo
Interaction between ERK and GSK3{beta} Mediates Basic Fibroblast Growth Factor-induced Apoptosis in SK-N-MC Neuroblastoma Cells
J. Biol. Chem., April 4, 2008; 283(14): 9248 - 9256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Pabla, S. Huang, Q.-S. Mi, R. Daniel, and Z. Dong
ATR-Chk2 Signaling in p53 Activation and DNA Damage Response during Cisplatin-induced Apoptosis
J. Biol. Chem., March 7, 2008; 283(10): 6572 - 6583.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M.-R. Ki, H.-R. Lee, M.-J. Goo, I.-H. Hong, S.-H. Do, D.-H. Jeong, H.-J. Yang, D.-W. Yuan, J.-K. Park, and K.-S. Jeong
Differential regulation of ERK1/2 and p38 MAP kinases in VacA-induced apoptosis of gastric epithelial cells
Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G635 - G647.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. H. Lash
Epidermal growth factor receptor ligands and renal epithelial cell proliferation
Am J Physiol Renal Physiol, March 1, 2008; 294(3): F457 - F458.
[Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
T. L. Johnson, M. B. Lai, J. C. K. Lai, and A. Bhushan
Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A
Evid. Based Complement. Altern. Med., February 29, 2008; (2008) nen011v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Lechner, N. A. Malloth, P. Jennings, D. Heckl, W. Pfaller, and T. Seppi
Opposing roles of EGF in IFN-{alpha}-induced epithelial barrier destabilization and tissue repair
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1843 - C1850.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M M Conradie, H de Wet, D D R Kotze, J M Burrin, F S Hough, and P A Hulley
Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo
J. Endocrinol., November 1, 2007; 195(2): 229 - 240.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Mitchell, P. Kabolizadeh, J. Ryan, J. D. Roberts, A. Yacoub, D. T. Curiel, P. B. Fisher, M. P. Hagan, N. P. Farrell, S. Grant, et al.
Low-Dose BBR3610 Toxicity in Colon Cancer Cells Is p53-Independent and Enhanced by Inhibition of Epidermal Growth Factor Receptor (ERBB1)-Phosphatidyl Inositol 3 Kinase Signaling
Mol. Pharmacol., September 1, 2007; 72(3): 704 - 714.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. C. Kiley and R. L. Chevalier
Species differences in renal Src activity direct EGF receptor regulation in life or death response to EGF
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F895 - F903.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. H. Joo, G. Liao, J. B. Collins, S. F. Grissom, and A. M. Jetten
Farnesol-Induced Apoptosis in Human Lung Carcinoma Cells Is Coupled to the Endoplasmic Reticulum Stress Response
Cancer Res., August 15, 2007; 67(16): 7929 - 7936.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Alderliesten, M. de Graauw, J. Oldenampsen, Y. Qin, C. Pont, L. van Buren, and B. van de Water
Extracellular Signal-Regulated Kinase Activation during Renal Ischemia/Reperfusion Mediates Focal Adhesion Dissolution and Renal Injury
Am. J. Pathol., August 1, 2007; 171(2): 452 - 462.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.